Pluri (PLUR) Return on Sales Growth (3y) (2014 - 2025)
Pluri (PLUR) Return on Sales Growth (3y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROS Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
5.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
0.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Pluri |
21.39 Mn |
21.87 Mn |
86,000.00 |
3,411.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
3,411.00 |
| Sep 30, 2025 |
62.00 |
| Jun 30, 2025 |
161.00 |
| Mar 31, 2025 |
32.00 |
| Jun 30, 2023 |
1,221.00 |
| Mar 31, 2023 |
1,172.00 |
| Dec 31, 2022 |
-3,169.00 |
| Jun 30, 2022 |
480.00 |
| Mar 31, 2022 |
629.00 |
| Jun 30, 2019 |
-650.00 |
| Mar 31, 2019 |
-666.00 |
| Dec 31, 2018 |
-165.00 |
| Sep 30, 2018 |
-2,184.00 |
| Dec 31, 2017 |
-103.00 |
| Jun 30, 2016 |
29.00 |
| Mar 31, 2016 |
23.00 |
| Dec 31, 2015 |
24.00 |
| Sep 30, 2015 |
-37.00 |
| Dec 31, 2014 |
-57.00 |
| Sep 30, 2014 |
-31.00 |
